REPROS THERAPEUTICS INC's ticker is and the CUSIP is 76028H959. A total of 2 filers reported holding REPROS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | -100.0% | 11 | -83.6% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 67 | +97.1% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 34 | +161.5% | 0.00% | – |
| Q1 2016 | $2,000 | -97.1% | 13 | -88.3% | 0.00% | -100.0% |
| Q4 2015 | $69,000 | +102.9% | 111 | +19.4% | 0.01% | +150.0% |
| Q3 2015 | $34,000 | +161.5% | 93 | +615.4% | 0.00% | +100.0% |
| Q2 2015 | $13,000 | +8.3% | 13 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $12,000 | -67.6% | 13 | -97.3% | 0.00% | -75.0% |
| Q4 2014 | $37,000 | – | 484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 3,450 | $5,969,000 | 0.26% |
| Citadel Advisors | 26,000 | $450,000 | 0.00% |